Subcutaneous abatacept versus intravenous abatacept: a phase IIIb noninferiority study in patients with an inadequate response to methotrexate.
Genovese MC, Covarrubias A, Leon G, Mysler E, Keiserman M, Valente R, Nash P, Simon-Campos JA, Porawska W, Box J, Legerton C 3rd, Nasonov E, Durez P, Aranda R, Pappu R, Delaet I, Teng J, Alten R.
Genovese MC, et al.
Arthritis Rheum. 2011 Oct;63(10):2854-64. doi: 10.1002/art.30463.
Arthritis Rheum. 2011.
PMID: 21618201
Free PMC article.
Clinical Trial.